Clay Thorp, Director, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 24,500 shares at $7.30 ($185K) on 2017-08-09, disclosed to the SEC on 2017-08-09.
Open-market sale of $185k CLSD by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.02 | 4,500 | $36K | 19.5% |
| 2 | $7.98 | 5,000 | $40K | 21.5% |
| 3 | $7.30 | 15,000 | $110K | 59.0% |
| Total | $7.57 avg | 24,500 | $185K | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |